Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 15/20 | 0.47 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.45 |
| ▸ | RAF1 | P04049 | 2/20 | 0.44 |
| ▸ | BRAF | P15056 | 2/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.43 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.43 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.43 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.43 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4551790 | 0.96 | HCAR3 (0.45) | MAPK14TNK2HCAR3 | |
| SCHEMBL4551562 | 0.95 | HCAR3 (0.44) | MAPK14TNK2HCAR3 | |
| SCHEMBL5484352 | 0.91 | CSF1R (0.50) | MAPK14TNK2RAF1BRAF | |
| SCHEMBL4408418 | 0.90 | CRHR1 (0.48) | MAPK14RAF1BRAFPLAUMAPK13 | |
| SCHEMBL5490162 | 0.90 | TNK2 (0.44) | MAPK14TNK2RAF1BRAFHCAR3 | |
| SCHEMBL14534670 | 0.90 | MAPK14 (0.46) | MAPK14RAF1BRAFPLAUMAPK13 | |
| SCHEMBL5487361 | 0.90 | MAPK14 (0.47) | MAPK14RAF1BRAFPLAUMAPK13 | |
| SCHEMBL5490935 | 0.88 | CRHR1 (0.45) | MAPK14RAF1BRAFPLAUMAPK13 | |
| SCHEMBL4551651 | 0.87 | CRHR1 (0.45) | MAPK14RAF1BRAFPLAUMAPK13 | |
| SCHEMBL14534471 | 0.86 | MAPK14 (0.50) | MAPK14RAF1BRAFPLAUMAPK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2035005-A2 | THERAPY USING CYTOKINE INHIBITORS | Kemia, INC. (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007146712-A2 | THERAPY USING CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007056016-A2 | BISAMIDE CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056016-A2 | BISAMIDE CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-05-18 | — | — | WO | disclosed |